Amirhossein Bahreyni

University of British Columbia — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index1.5kcitations60works9.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced biosensing and bioanalysis techniques(14), RNA Interference and Gene Delivery(11), Adenosine and Purinergic Signaling(9), Viral Infections and Immunology Research(8), Virus-based gene therapy research(6)

Publications60 total

Cellular protein quality control in viral myocarditis: molecular mechanisms and therapeutic implication
Microbiology and Molecular Biology Reviews·2025Open Access
Developing a Personalized Cancer Nanovaccine Using Coxsackievirus‐Reprogrammed Cancer Cell Membranes for Enhanced Anti‐Tumor Immunity
Advanced Science·2025· 1 citedOpen Access
Mitochondrial injury and complement dysregulation are drivers of pathological inflammation in viral myocarditis
Journal of Virology·2025· 3 citedOpen Access
Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry
Viruses·2024· 6 citedOpen Access
Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives
Molecular Biology Reports·2024· 2 cited
Oncolytic virus-based combination therapy in breast cancer
Cancer Letters·2024· 36 citedOpen Access
Synergistic Viro-chemoimmunotherapy in Breast Cancer Enabled by Bioengineered Immunostimulatory Exosomes and Dual-Targeted Coxsackievirus B3
ACS Nano·2024· 20 citedOpen Access
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
BMC Medicine·2023· 20 citedOpen Access
Engineering a facile and versatile nanoplatform to facilitate the delivery of multiple agents for targeted breast cancer chemo-immunotherapy
Biomedicine & Pharmacotherapy·2023· 15 citedOpen Access
Mitochondria Dysfunction at the Heart of Viral Myocarditis: Mechanistic Insights and Therapeutic Implications
Viruses·2023· 32 citedOpen Access
Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies
Biomedicine & Pharmacotherapy·2023· 13 citedOpen Access
Engineering a facile and versatile nanoplatform to facilitate the delivery of multiple agents for targeted breast cancer chemo-immunotherapy
Research Square (Research Square)·2023Open Access
Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3
Molecular Therapy — Oncolytics·2022· 4 citedOpen Access
Coxsackievirus Protease 2A Targets Host Protease ATG4A to Impair Autophagy
Viruses·2022· 6 citedOpen Access
A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice
Cancer Letters·2022· 23 citedOpen Access
Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model
Journal of Neuroinflammation·2022· 21 citedOpen Access
Sublethal Enteroviral Infection Exacerbates Disease Progression in an ALS Mouse Model
Research Square (Research Square)·2021Open Access
Autophagy Receptor Protein Tax1-Binding Protein 1/TRAF6-Binding Protein Is a Cellular Substrate of Enteroviral Proteinase
Frontiers in Microbiology·2021· 11 citedOpen Access
FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses
Journal of Virology·2021· 13 citedOpen Access
Coxsackievirus B3 targets TFEB to disrupt lysosomal function
Autophagy·2021· 41 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Seyed Mahdi Hassanian(19), Honglin Luo(18), Majid Khazaei(17), Amir Avan(17), Yasir Mohamud(16), Mikhail Ryzhikov(15), Khalil Abnous(13), Seyed Mohammad Taghdisi(13), Mohammad Ramezani(8), Yuan Chao Xue(8), Gordon A. Ferns(6), Mojtaba Shafiee(6), Noor Mohammad Danesh(6), Hamid Fiuji(6), Farzad Rahmani(5), Mona Alibolandi(5), Mohammad Ramezani(5), Huitao Liu(5), Afsane Bahrami(4), Rezvan Yazdian‐Robati(4)